BioLargo, Inc. (OTCQB:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact.
Alberta Innovates commits to provide significant funding
Westminster, CA – December 22, 2020 – BioLargo, Inc. (OTCQB:BLGO),
developer of cutting-edge environmental technologies and a full-service
engineering company, announced today that its Canadian subsidiary has received
grant funding necessary to begin the design and construction of a full-scale farm-wide
“zero liquid discharge” wastewater treatment and reuse project at Sunworks Farm,
an organic poultry producer in Alberta, Canada.
Scheduled to begin operating next year, BioLargo will design,
build, install and operate a custom water treatment train featuring its patented
Advanced Oxidation System (AOS) technology. The system will treat all
wastewater produced by farming operations and convert it to reusable water,
saving the farm money and reducing its environmental impact. This project will
make Sunworks Farm the first “zero liquid discharge” poultry facility in
Alberta Canada, a significant technical and environmental achievement for both
companies and for the Canadian poultry industry.
Alberta Innovates has committed funding for the project through
the Water Innovation Program (https://albertainnovates.ca/programs/water-innovation/).
“BioLargo’s Advanced Oxidation System (AOS) technology has
the potential to protect Alberta’s water quality and improve water reuse at
Sunworks Farm. Advancing the reuse of wastewater through innovation is an
important way to support economic development and environmental stewardship in
Alberta”, says Dr. Brett Purdy, Executive Director of Environmental Innovation
at Alberta Innovates.
To learn more about BioLargo Water and the AOS, visit www.biolargowater.com and the website
of the parent company BioLargo at www.biolargo.com.
About BioLargo, Inc.
BioLargo, Inc. is an innovator of technology-based products and
environmental engineering solutions provider driven by a mission to “make life
better”. We feature unique disruptive
solutions to deliver clean air, clean water and a clean, safe environment (www.biolargo.com). Our
engineering division features experienced professional engineers dedicated to
integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our
industrial odor control division, ONM Environmental, Inc. (www.onmenvironmental.com) features
CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which
eliminates the odor-causing compounds and VOCs rather than masking them, and is
now winning over leading companies in the solid waste handling and wastewater
industries and other industries that contend with malodors and VOCs. Our subsidiary
BioLargo Water (www.biolargowater.ca) develops
the Advanced Oxidation System "AOS," a disruptive industrial water
treatment technology designed to eliminate waterborne pathogens and
recalcitrant contaminants with better energy-efficiency and lower operational
costs than incumbent technologies. We are a minority stockholder of and
technology licensor to our subsidiary Clyra Medical which features its
breakthrough product Clyraguard ( www.clyramedical.com/clyraguard), an FDA
Registered, hospital grade disinfectant for personal protective equipment
including facemasks, proven 99.999% effective and safe for skin, as well as its
other products offering gentle solutions for chronic infected wounds to promote
infection control and regenerative tissue therapy.
About Alberta Innovates
Alberta Innovates invests in research, innovation and
entrepreneurship to drive provincial economic growth and diversity. We ignite
the power of innovation through our work with researchers, industry and
entrepreneurs to move Alberta to a lower-carbon future, promote the responsible
use of land and water, and contribute to the improved health and well-being of
Albertans.
Alberta Innovates provides technical expertise,
entrepreneurial advice and support, opportunities for partnerships, and funding
to advance the best ideas. We support a broad range of research and innovation
activity – from discovery to use. Collaboration is at the heart of what we
do – bringing together bright minds and great ideas.
Contact Information
Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863
Safe Harbor Act
During the course of the stockholder
presentation, BioLargo may make “forward-looking statements” within the meaning
of the safe harbor provisions of the United States Private Securities
Litigation Reform Act of 1995, regarding future events or the future financial
performance of the company that are subject to change. Actual results may
differ from expectations, estimates and projections and, consequently, you
should not rely on these forward-looking statements as predictions of future
events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,”
“anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,”
“predicts,” “potential,” “continue,” and similar expressions are intended to
identify such forward-looking statements. These forward-looking statements
involve significant risks and uncertainties that could cause the actual results
to differ materially from the expected results.
The event, organized by Nightingale 2030 Resilience Fund, will honor frontline healthcare workers around the world
Westminster, CA – December 21, 2020 – BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable technologies, full-service environmental engineering firm and parent company to Clyra Medical Technologies, makers of Clyraguard Personal Protection Spray, today announced support for an innovative and timely virtual theatrical event inspired by the life and legacy of the founder of modern nursing, Florence Nightingale, titled What Would Flo Do?. The play is being produced by the Nightingale 2030 Resilience Fund, a non-profit organization that supports nurses and midwives around the world.
What Would Flo Do? is a virtual documentary play premiering on Tuesday, December 22 on Zoom, directed by Tony Award winner Tim Kashani. It will take audiences into the world of nurses today and into the world of Florence Nightingale in her later years as a thought-leader, statistician, change agent and founder of the nursing profession. The premiere highlights the Thank-a-Nurse Campaign sponsored by the Nightingale 2030 Resilience Fund. This play is the first in a series with additional showings planned for 2021 and beyond.
To watch What Would Flo Do?, visit https://www.whatwouldflodo.com and click “Join Zoom” at 4:30pm PST on December 22, 2020. Additional information on What Would Flo Do? and the Nightingale 2030 Resilience Fund is available at https://nightingale2030.org
Clyraguard can be purchased online at https://truepurposebrands.com/,
with a percentage of profits from sales to support the Nightingale 2030
Resilience Fund.
2020 is the 200th anniversary of the birth
Florence Nightingale, the founder of modern nursing who trained field nurses
during the Crimean War. To honor her memory, the World Health Organization has
called 2020 the “International Year of the Nurse and Midwife” in support of
nurses’ and midwives’ crucial role in advancing healthcare around the world –
especially in light of the COVID pandemic.
About Nightingale 2030 Resilience Fund
The Nightingale 2030 Resilience Fund is supporting nurses,
midwives, and caregivers throughout their lives beginning when licensed or
certified in healthcare specialties continuing through retirement. We give
nurses the tools and resources to be resilient in their profession, personal
lives, and to help out in their communities.
The Nightingale 2030 Resilience Fund is a 501(c)(3)
non-profit organization with fiscal sponsorship from Partnerships For Change.
The Nightingale 2030 Resilience Fund is committed to making a difference in the advancement of the United Nations Sustainable Development Goals (SDGs). Goals that impact the world in which nurses play a vital role: no poverty; no hunger; good health; quality education; gender equality; clean water and sanitation; renewable energy; good jobs & economic growth; innovation & infrastructure; reduced inequalities; sustainable cities & communities; responsible consumption: climate action; life below water; life on land; peace & justice; and partnerships for goals!
About True Purpose Brands
True Purpose Brands is dedicated to curating products that are
clean, safe, and sustainably formulated using proprietary science. All of their
innovative products are non-toxic and eco-friendly, meaning they are safe for
people, pets, plants, and the planet.
Their True Purpose is to instill confidence that their products perform to a New Standard of Safe and Clean.
About BioLargo, Inc.
BioLargo, Inc. is an innovator of technology-based products and
environmental engineering solutions provider driven by a mission to “make life
better”. We feature unique disruptive
solutions to deliver clean air, clean water and a clean, safe environment (www.biolargo.com). Our
engineering division features experienced professional engineers dedicated to
integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our
industrial odor control division, ONM Environmental, Inc. (www.onmenvironmental.com) features
CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which
eliminates the odor-causing compounds and VOCs rather than masking them, and is
now winning over leading companies in the solid waste handling and wastewater
industries and other industries that contend with malodors and VOCs. Our subsidiary
BioLargo Water (www.biolargowater.ca) develops
the Advanced Oxidation System "AOS," a disruptive industrial water
treatment technology designed to eliminate waterborne pathogens and
recalcitrant contaminants with better energy-efficiency and lower operational
costs than incumbent technologies. We are a minority stockholder of and
technology licensor to our subsidiary Clyra Medical which features its
breakthrough product Clyraguard (www.clyramedical.com/clyraguard), an FDA
Registered, hospital grade disinfectant for personal protective equipment
including facemasks, proven 99.999% effective and safe for skin, as well as its
other products offering gentle solutions for chronic infected wounds to promote
infection control and regenerative tissue therapy.
Contact Information
Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863
Westminster, CA – December 21, 2020 – BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable technologies and a full-service environmental engineering company, today announced that its current fourth quarter revenues of approximately $750,000 will result in new quarterly and annual records for the company.
In addition to setting revenue records, BioLargo also
significantly reduced its debt obligations during the year. At December 31,
2019, its balance sheet showed approximately $4.6 million in notes payable and
lines of credit, not including solely owed obligations of its partially owned
subsidiary Clyra Medical. During this calendar year, BioLargo reduced the $4.6 million
owed by over $2.8 million to approximately $1.7 million. Of that amount, $357,000
are SBA Paycheck Protection Act loans (which management expects will be
forgiven in accordance with SBA’s terms), $200,000 will be converted to equity
at maturity, and the remaining approximately $1.1 million may be converted by
the investors and if not, will mature in August 2021.
BioLargo CEO Dennis P. Calvert commented, “I am proud of our
team’s accomplishments in 2020, and am optimistic that we can continue the
momentum next year and further improve our financial condition with successful execution
of projects and contracts already in hand, as well as new product launches. Of
course, multiple factors may affect the timing and amount of our sales,
including uncertainties and unusual challenges related to the pandemic, and the
obvious challenges inherent in introducing new technologies to the market.”
In a presentation recorded at the LD Micro virtual investor
conference on December 14, 2020, Mr. Calvert explained that the company needs
to reach approximately $1.25 million in quarterly revenues to get to cash-flow positive
for operations supported by BioLargo (which excludes Clyra, which is independently
financed). In the video, available below, he also explained the drivers behind
the record revenues and detailed the company’s plans to launch its long-anticipated
water treatment technologies, the BioLargo AOS and BioLargo AEC, in 2021.
Watch the video here: https://www.biolargo.com/ld-micro-conference-video
See caution regarding forward looking statements, below.
About BioLargo, Inc.
BioLargo, Inc. is an innovator of technology-based products and
environmental engineering solutions provider driven by a mission to “make life
better”. We feature unique disruptive
solutions to deliver clean air, clean water and a clean, safe environment (www.biolargo.com). Our
engineering division features experienced professional engineers dedicated to
integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our
industrial odor control division, ONM Environmental, Inc. (www.onmenvironmental.com) features
CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which
eliminates the odor-causing compounds and VOCs rather than masking them, and is
now winning over leading companies in the solid waste handling and wastewater
industries and other industries that contend with malodors and VOCs. Our subsidiary
BioLargo Water (www.biolargowater.ca) develops
the Advanced Oxidation System "AOS," a disruptive industrial water
treatment technology designed to eliminate waterborne pathogens and
recalcitrant contaminants with better energy-efficiency and lower operational
costs than incumbent technologies. We are a minority stockholder of and
technology licensor to our subsidiary Clyra Medical which features its
breakthrough product Clyraguard ( www.clyramedical.com/clyraguard), an FDA
Registered, hospital grade disinfectant for personal protective equipment
including facemasks, proven 99.999% effective and safe for skin, as well as its
other products offering gentle solutions for chronic infected wounds to promote
infection control and regenerative tissue therapy.
Contact Information
Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863
Safe Harbor Act
During the course of the stockholder
presentation, BioLargo may make “forward-looking statements” within the meaning
of the safe harbor provisions of the United States Private Securities
Litigation Reform Act of 1995, regarding future events or the future financial
performance of the company that are subject to change. Actual results may
differ from expectations, estimates and projections and, consequently, you
should not rely on these forward-looking statements as predictions of future
events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,”
“anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,”
“predicts,” “potential,” “continue,” and similar expressions are intended to
identify such forward-looking statements. These forward-looking statements
involve significant risks and uncertainties that could cause the actual results
to differ materially from the expected results.
WESTMINSTER, CA – December 9, 2020 / BioLargo (OTCQB:BLGO), developer of environmental technologies and a full-service engineering company, today announced that it will be presenting at the 13th annual LD Micro Main Event investor conference on Monday, December 14 at 6:00 AM PST / 9:00 AM EST. BioLargo President and CEO Dennis P. Calvert will present to a live, virtual audience.
Mr. Calvert will showcase BioLargo’s portfolio of
disruptive technologies in water treatment, air quality control, PFAS
remediation, and COVID-19 protection. He will cover the drivers for the
company’s recent record revenues and explain why this a pivotal period for the
company and its investors. To learn more about BioLargo, visit www.biolargo.com and visit
the company’s blog at www.biolargo.blogspot.com.
Register to watch the virtual presentation here: ve.mysequire.com/. Registration is free.
LD Micro’s 13th annual Main Event will feature a new and unique format, with companies presenting for 10 minutes, followed by 10 minutes of Q&A by a panel of investors and analysts. With over 250 companies scheduled to present, over two million investors invited, and a one-on-one interview with NBA legend, entrepreneur, philanthropist and philosopher Shaquille O’Neal, this year’s program promises something for everyone.
"The time has finally come to do something different in the virtual conference world. Let’s see if we can pull off something that can be enjoyed by both executives and investors alike,” stated Chris Lahiji, Founder of LD Micro, now a wholly owned subsidiary of SRAX, Inc.
The Main Event will take place on December 14th and 15th, exclusively on the Sequire Virtual Events platform.
View BioLargo’s profile here: http://www.ldmicro.com/profile/BLGO
Profiles powered by LD Micro
About BioLargo, Inc.
BioLargo, Inc. is an innovator of technology-based products and environmental engineering solutions provider driven by a mission to “make life better”. We feature unique disruptive solutions to deliver clean air, clean water and a clean, safe environment (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, ONM Environmental, Inc. (www.onmenvironmental.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System "AOS," a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. We are a minority stockholder of and technology licensor to our subsidiary Clyra Medical which features its breakthrough product Clyraguard (www.clyramedical.com/clyraguard), an FDA Registered, hospital grade disinfectant for personal protective equipment including facemasks, proven 99.999% effective and safe for skin, as well as its other products offering gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.
About LD Micro/SEQUIRE
LD Micro began in 2006 with the sole purpose of being an independent resource to the microcap world. What started as a newsletter highlighting unique companies, has transformed into the pre-eminent event platform in the space. For more information, please visit ldmicro.com.
The upcoming Main Event will be highlighting a new format that will benefit both executives and the investors tuning in from all over the globe.
In September 2020, LD Micro. Inc. was acquired by SRAX, Inc., a financial technology company that unlocks data and insights for publicly traded companies. Through its premier investor intelligence and communications platform, Sequire, companies can track their investors’ behaviors and trends and use those insights to engage current and potential investors across marketing channels. For more information on SRAX, visit srax.com and mysequire.com.
Contact:
Name: Dennis P. Calvert, President and CEO of
BioLargo
Phone: 888-400-2863
Address: 14921 Chestnut Street, Westminster CA,
92683
Email: dennis.calvert@biolargo.com
Source: BioLargo via LD Micro
Source: Proactive Investors (https://ca.proactiveinvestors.com/companies/news/935546/biolargo-installs-cupridyne-clean-air-quality-control-systems-for-clients-in--break-out-moment--935546.html)
BioLargo Inc (OTCQB:BLGO) CEO Dennis Calvert tells Proactive the group's subsidiary ONM Environmental Inc recently installed several large and financially significant CupriDyne Clean air quality control systems at public and private landfills.
Calvert says these projects will lead to breaking records in revenue numbers, and are noteworthy because of their size, sophistication, and scope relative to past projects. They feature CupriDyne Clean, the company's award-winning, cost-effective volatile organic compounds- (VOCs) control product that eliminates odor-causing compounds and VOCs rather than masking them.
Subsidiary ONM Environmental leading the way
Westminster, CA – December 1, 2020 – ONM Environmental, Inc., a subsidiary of BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable technologies and a full-service environmental engineering company, has recently installed several large and financially significant CupriDyne Clean air quality control systems at public and private landfills. These projects are noteworthy because of their size, sophistication, and scope relative to past projects, and feature CupriDyne Clean, the company’s award-winning cost-effective odor and VOC control product that eliminates odor-causing compounds and VOCs rather than masking them.
These most recent projects are driving increasing sales for ONM
in recent months. Management anticipates these projects will propel the company
to record revenues in the fourth quarter, assuming no delays in project
execution occur as a result of significant new COVID-related government
shutdowns or regulations.
A video of the trailer can be viewed here: https://www.biolargo.com/cupridyne-misting-trailer
ONM also began working with two municipalities in Southern
California, one of which required the installation of a 4,000-foot-long perimeter
misting system for a landfill. The second involved ONM delivering multiple of
its new portable misting trailers which use its flagship product CupriDyne
Clean on an ongoing basis.
President of ONM Environmental, Joe Provenzano stated, “We
have a reputation as a company that delivers the highest quality and most
dependable air quality control solutions and deployment systems, even in some
of the toughest on-the-ground conditions in industry. We are winning larger and
more financially significant projects than ever before.”
The company provided a photo gallery from recent installations
(including the new portable trailers). This photo gallery is available here: https://www.biolargo.com/case-studies
About BioLargo, Inc.
BioLargo, Inc. is an innovator of technology-based products and
environmental engineering solutions provider driven by a mission to “make life
better”. We feature unique disruptive
solutions to deliver clean air, clean water and a clean, safe environment (www.biolargo.com). Our
engineering division features experienced professional engineers dedicated to
integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our
industrial odor control division, ONM Environmental, Inc. (www.onmenvironmental.com) features
CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which
eliminates the odor-causing compounds and VOCs rather than masking them, and is
now winning over leading companies in the solid waste handling and wastewater
industries and other industries that contend with malodors and VOCs. Our
subsidiary BioLargo Water (www.biolargowater.ca) develops
the Advanced Oxidation System "AOS," a disruptive industrial water
treatment technology designed to eliminate waterborne pathogens and
recalcitrant contaminants with better energy-efficiency and lower operational
costs than incumbent technologies. We are a minority stockholder of and
technology licensor to our subsidiary Clyra Medical which features its
breakthrough product Clyraguard (www.clyramedical.com/clyraguard), an FDA
Registered, hospital grade disinfectant for personal protective equipment
including facemasks, proven 99.999% effective and safe for skin, as well as its
other products offering gentle solutions for chronic infected wounds to promote
infection control and regenerative tissue therapy.
Contact Information
Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863
Safe Harbor Act
During the course of the stockholder
presentation, BioLargo may make “forward-looking statements” within the meaning
of the safe harbor provisions of the United States Private Securities
Litigation Reform Act of 1995, regarding future events or the future financial
performance of the company that are subject to change. Actual results may
differ from expectations, estimates and projections and, consequently, you
should not rely on these forward-looking statements as predictions of future
events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,”
“anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,”
“predicts,” “potential,” “continue,” and similar expressions are intended to
identify such forward-looking statements. These forward-looking statements
involve significant risks and uncertainties that could cause the actual results
to differ materially from the expected results.
Source: Proactive Investors (https://ca.proactiveinvestors.com/companies/news/934217/biolargo-s-water-technologies-closer-to-commercialization-reports-record-3q-934217.html)
BioLargo, Inc (OTCQB:BLGO) CEO Dennis Calvert tells Proactive its 3Q financial results saw its revenue rise 26% year-over-year to a record $0.67 million. Calvert says the group is ramping up several of its water technologies to prepare for commercialization including the AOS and the AEC, which he says will lead to first sales.
What's more, its industrial operating divisions each have a backlog of revenue-generating projects that collectively exceed $2 million, which it says will provide “reliable revenue” into 2021.
BioLargo and its subsidiary Clyra Medical Technologies are rolling out Clyraguard around the country, and it's starting to turn some heads. Now that the product is available on the company's website and on Amazon, the timing is perfect.
You can get to these articles right here:
Earlier this year, BioLargo announced the formation of a joint venture with BKT & Tomorrow Water to launch BioLargo’s patented odor and VOC control product CupriDyne Clean (www.cupridyne.com) into the Asian market under the brand name “Odin”. The new join venture was designed to manufacture and support distribution of the odor and VOC control products developed and sold by its subsidiary ONM Environmental, Inc. (www.onmenvironmental.com) in multiple countries throughout Asia, focusing initially on BKT’s established water and wastewater customer base.
BKT is a leading wastewater treatment solutions provider
operating in the USA, South Korea, and Vietnam with a reputation for adopting
innovative, environmentally sustainable technologies and practices. In the
agreement between BioLargo and BKT, it was planned that the joint venture would
eventually move its headquarters to the city of Daegu, which is a center for
high-tech innovation in South Korea.
The BKT/BioLargo joint venture (Odin) is now officially
moving its headquarters to the Korea Water Cluster in Daegu. The Korea
Water Cluster is a newly opened water innovation hub in Daegu that provides
significant business, scientific, engineering, human resources, and logistical
assets to companies. Odin is set to be the first international joint venture
headquartered at the Korea Water Cluster campus.
Water clusters and innovations groups exist all over the world, but the Korea Water Cluster is unique because of its significant physical footprint in Daegu, its substantial physical resources, and the funding it has received from the South Korean government. The Korea Water Cluster’s campus spans over 14 square kilometers, with state-of-the art testing facilities and business support centers.
 |
| Overview of Korea Water Cluster facilities (source: www.watercluster.or.kr) |
James Kim, COO of BKT, commented on the importance of the
move to Daegu, “the Water Cluster will be a hub for R&D in the water industry, and it will introduce innovative
technologies in one place, providing opportunity for collaboration and
cooperation among companies and ventures.”
He continued, “Korea Water Cluster will be a test bed and
showcase for many innovative technologies not only for Korean clients but also
many other clients in Asia. Odor is one of the major issues that wastewater
treatment plants would like to remove, and it is becoming more important. By
moving its headquarters to this Water Cluster, Odin will be naturally exposed
to more clientele in Korea and also in Asia. BioLargo and Tomorrow Water signed
an MOU with the City of Daegu at the WEFTEC last year, and the Mayor of Daegu
promised strong support on market expansion in this region. Odin is the first
foreign invested joint venture who moved into this cluster.”
Odin’s move to the Korea Water Cluster comes at a time when
the joint venture is working to establish its manufacturing base for odor and
VOC control products in South Korea. Not only will the move provide access for
Odin to key opinion leaders in the water innovation industry in South Korea,
but it will allow for significant business-to-business collaboration as the
joint venture partners works to market Odin products in the region.
A
Regenerative Thermal Oxidizer is a device that destroys unwanted organic air
contaminants produced as a result of the phenolic resin production process. An
RTO is a highly energy-efficient technology that uses waste heat to eliminate organic
air contaminants, and is a crucial piece of equipment for this chemical plant.
The plant
is preparing to shut down an existing, older RTO and re-route the exhaust
treated by that RTO to a newer, much larger and more efficient RTO. This will result
in significant energy efficiency and cost savings improvements to the facility.
The work to reconfigure these RTO systems is not trivial, requiring substantial
engineering and design work to ensure it proceeds safely and efficiently. BLEST
has been contracted to conduct the initial engineering work to assess the
feasibility of the RTO reconfiguration project. BLEST engineers have
significant experience engineering and designing RTO systems, with some of its
engineers having designed multiple RTO systems for the facility.
About BioLargo, Inc.
BioLargo, Inc. is an innovator of technology-based products and
environmental engineering solutions provider driven by a mission to “make life
better”. We feature unique disruptive
solutions to deliver clean air, clean water and a clean, safe environment (www.biolargo.com). Our
engineering division features experienced professional engineers dedicated to
integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our
industrial odor control division, ONM Environmental, Inc. (www.onmenvironmental.com) features
CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which
eliminates the odor-causing compounds and VOCs rather than masking them, and is
now winning over leading companies in the solid waste handling and wastewater
industries and other industries that contend with malodors and VOCs. Our
subsidiary BioLargo Water (www.biolargowater.ca) develops
the Advanced Oxidation System "AOS," a disruptive industrial water
treatment technology designed to eliminate waterborne pathogens and
recalcitrant contaminants with better energy-efficiency and lower operational
costs than incumbent technologies. We are a minority stockholder of and technology
licensor to our subsidiary Clyra Medical which features its breakthrough product
Clyraguard ( www.clyramedical.com/clyraguard), an FDA
Registered, hospital grade disinfectant for personal protective equipment
including facemasks, proven 99.999% effective and safe for skin, as well as its
other products offering gentle solutions for chronic infected wounds to promote
infection control and regenerative tissue therapy.
Contact Information
Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863
Safe Harbor Act
During the course of the stockholder
presentation, BioLargo may make “forward-looking statements” within the meaning
of the safe harbor provisions of the United States Private Securities
Litigation Reform Act of 1995, regarding future events or the future financial
performance of the company that are subject to change. Actual results may
differ from expectations, estimates and projections and, consequently, you
should not rely on these forward-looking statements as predictions of future
events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,”
“anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,”
“predicts,” “potential,” “continue,” and similar expressions are intended to
identify such forward-looking statements. These forward-looking statements
involve significant risks and uncertainties that could cause the actual results
to differ materially from the expected results.
For many years, BioLargo has sponsored fellowships offered by the National Water Research Institute (NWRI) to graduate students in the US who focus on cutting-edge water research. This $5,000 fellowship recognizes students who research the technical and scientific aspects of advanced water and wastewater treatment.
This year, we are happy to announce that the NWRI-BioLargo
Graduate Fellowship has been awarded to Lorianne Shultz, a PhD student at the
University of Central Florida. Shultz’s research project, which she is
completing in the laboratory of Dr. Titel Jurca, is called “Chlorine Stable
Heterogeneous Catalysts for the Remediation of Stubborn Water Pollutants”.
 |
| Lorianne Shultz, NWRI- BioLargo Fellowship winner |
Lorianne explained to us the importance of her research, “Pharmaceuticals
and personal care products are accumulating in our waterways at alarming rates;
this is especially true with the world’s growing population. This issue can be
remediated through heterogenous catalytic degradation of these pollutants, a methodology
that I believe is commonly overlooked in the water-industry. I was thrilled to
receive this fellowship as it helps validate the use of catalytic materials for
water-remediation and these funds help me expand this field of research
further. I am excited to be working in connection with BioLargo, a company so
dedicated to this field and at the forefront of improvement for water treatment
systems.”
Dennis P. Calvert, President & CEO of BioLargo,
commented, “Shultz’s research goals align well with NWRI’s mission to protect
and improve water management in the US, and they also align with BioLargo’s
vision of seeking innovative new methods of addressing tough contaminants that
threaten the health and safety of people around the world. We are thrilled to
sponsor her work, and we are excited to learn from her research.”
NWRI is a 501c3 nonprofit that collaborates with water
utilities, regulators, and researchers in innovative ways to help develop new,
healthy sources of drinking water. To learn more about NWRI’s graduate
fellowship program, go to the NWRI website: https://www.nwri-usa.org/fellowships.
BioLargo
subsidiary Clyra Medical Technologies Joins Forces with Powerplay Retail to
Ensure
Broad
Availability of Revolutionary Product to Safeguard Against Airborne Viruses
Westminster, CA – October 14, 2020 – Just in time for Amazon Prime Day, BioLargo, Inc. (OTCQB:BLGO), developer of sustainable life science technologies, today announced that Clyraguard, the personal disinfectant and germicidal spray that safely and easily decontaminates masks and face coverings, is now available at the Clyra Medical Store on Amazon.com. Clyraguard is manufactured by BioLargo’s subsidiary Clyra Medical Technologies, a med-tech company with deep experience fighting hospital-acquired infections with innovative technologies.
In addition, Clyra Medical announced a partnership with Powerplay Retail, an agency and distributor that has helped launch some of the best-known consumer products in the world, to roll-out Clyraguard to major retailers nationwide. Powerplay Retail brings to bear relationships with some of the world’s biggest online and in-store retailers, including more than 80 of the largest, most recognizable retailers in the United States.
BioLargo President & CEO Dennis Calvert commented, “We have assembled an exceptional team to execute a multi-phase roll out plan for Clyraguard. This Amazon launch, in partnership with Powerplay Retail, is another important step toward maximizing consumer access to this valuable product.”
“As we continue to battle this unprecedented pandemic, Clyraguard provides an embedded layer of iodine on one’s mask or face covering for additional protection against unwanted pathogens, including the SARS-CoV-2 virus, without having to remove your mask,” said Steve Harrison, CEO, Clyra Medical Technologies. “Until now, this hospital-grade disinfectant was available only to healthcare professionals. Making Clyraguard available on Amazon.com, as well as partnering with Powerplay Retail, ensures we can deliver a much-needed solution to consumers nationwide.”
Clyraguard has shown complete inactivation of SARS-CoV-2 (COVID-19), according to recent testing at University of Texas Medical Branch at Galveston, and is based on Clyra Medical’s original advanced wound care technology, which received 510(k) clearance from the Food and Drug Administration (FDA). Clyraguard is a hospital-grade, FDA-registered disinfectant that is specifically indicated for PPE, like masks and face coverings.
Clyraguard has been rigorously tested and proven to be safe and long-lasting, providing an extremely high 99.999% antimicrobial efficacy against viruses, bacteria and fungi. Gentle and safe, its eco-friendly ingredients are mineral-based, alcohol-free, non-toxic, non-irritating and non-sensitizing.
Available in 4 oz.
spray bottle, the personal protection spray is small enough for a purse or pocket
yet contains two months of supply with typical usage,
and for travelers, Clyraguard classifies under
current TSA hand sanitizer exemptions. Clyraguard is now available to consumers online at www.clyramedical.com, the Clyra
Medical Store on Amazon.com, and soon to be
available at retailers nationwide.
About BioLargo, Inc.
BioLargo, Inc. is an innovator of technology-based products and environmental engineering solutions provider driven by a mission to “make life better”. We feature unique disruptive solutions to deliver clean air, clean water and a clean, safe environment (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, ONM Environmental, Inc. (www.onmenvironmental.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System "AOS," a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. We are a minority stockholder of and technology licensor to our subsidiary Clyra Medical which features its breakthrough product Clyraguard ( www.clyramedical.com/clyraguard), an FDA Registered, hospital grade disinfectant for personal protective equipment including facemasks, proven 99.999% effective and safe for skin, as well as its other products offering gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.
About Clyra Medical Technologies
Clyra Medical Technologies, is a subsidiary of BioLargo, Inc. (OTCQB:BLGO), a sustainable science, technology and full-service environmental engineering company that makes life better by delivering world-class products and services across a broad range of industries, with a drive to deliver solutions in clean water and wastewater treatment, clean air and air quality control, and advanced antimicrobials for healthcare.
About Powerplay Retail
Powerplay Retail is a privately held, Minnesota based company with offices in Bentonville, Arkansas, and Shenzhen China. With over 250 years of combined retail experience bringing brands like Beats by Dr. Dre and GoPro to consumers they continue to vet and identify new retail opportunities to best serve their brand and retail partners. For more information on Powerplay Retail, visit powerplayretail.com.
Contact
Dennis P. Calvert
President and CEO,
BioLargo, Inc.
888-400-2863
Over the past few months, BioLargo pivoted to develop and deliver solutions to help combat the COVID-19 pandemic, including Clyraguard Personal Protection Spray, manufactured and sold by our subsidiary Clyra Medical Technologies. At the outset of the pandemic, we recognized that our iodine-based technologies would make a meaningful contribution to the fight against SARS-CoV-2 (the virus that causes COVID-19). Our response is directly in line with our mission statement to “make life better” because nothing is more important right now than helping protect people against this virus.
Last week at the 27th Octane High Tech Awards, BioLargo was honored for its contribution to the fight against COVID with a “COVID-19 Response Recognition Award”. We thank the Octane team for this honor, and we are humbled to have been recognized among such incredible Orange County based innovators.
The award highlighted BioLargo’s agile response to COVID. They
noted that the company’s subsidiary Clyra Medical Technologies worked quickly
to roll out Clyraguard Personal Protection Spray (www.clyramedical.com/clyraguard),
which recently launched to great enthusiasm, with sales and distribution
presently ramping up through national partners.
Clyraguard, an FDA-registered hospital-grade disinfectant,
offers an additional line of defense against COVID-19. It helps protects
mask-wearers from cross contamination by providing quick, safe, effective
on-the-go decontamination of masks and other noncritical PPE. It has been
tested and proven effective to completely inactivate SARS-CoV-2 (COVID-19) in a published study conducted
by Galveston National Lab (UTMB-Galveston), and it is proven to be non-toxic,
non-irritating, non-sensitizing, safe on skin, and eco-friendly.
Launching this product was no easy task – Clyra set up contract
manufacturing capable of delivering up to 1 million units per month, secured
FDA registration, built a full-scale marketing campaign that is currently
launching, and established partnerships with national distributors.
BioLargo also advanced its proprietary iodine technology to
be used as an environmental disinfectant. Already, third-party
studies were conducted that proved the
product, derived from BioLargo’s CupriDyne® technology, achieving complete
inactivation against SARS-CoV-2 in only 10 minutes.
This award is not the first time that BioLargo has been
honored by Octane at their HTA event. In 2017, BioLargo received an
Octane award for Horizontal Disruption because of the company’s diverse
innovative life sciences technologies. The following year, BioLargo CEO Dennis
P. Calvert was invited to be a judge for the 2018 HTA awards alongside
decorated entrepreneur Shawn Dougherty (who is now Clyra Medical Technologies’
Chief Revenue Officer). We believe organizations like Octane, which is Orange
County's premier tech incubator, are crucial in times like these, as they
promote the advancement of critically important innovative technologies that
help make people’s lives better.
On a Clyraguard-related note – we are anxious to update
everyone on the advancement of Clyraguard sales, so keep an eye out for more
Clyraguard news!
